Medindia

X

Clinical and Pre-Clinical Results for the LensAR Laser System for Cataract Surgery and Presbyopia Treatment to be Presented at ASCRS

Thursday, March 25, 2010 Research News J E 4
Advertisement
WINTER PARK, Fla., March 25 LensAR, Inc., a leading developer of next generation laser technology for cataract surgery and other ocular applications, today announced that four of the company's scientific collaborators will present clinical and pre-clinical data for the LensAR Laser System at the upcoming 2010 Annual Meeting of the American Society of Cataract and Refractive Surgery (ASCRS). The presentations will include results from studies designed to assess the performance of the LensAR Laser System in cataract surgery and the treatment of presbyopia. The conference will be held April 9-14, 2010 in Boston, MA.

Details for the LensAR presentations are as follows:

In addition to the data presentations, LensAR will also host a number of featured presentations by several of the industry's leading surgeons at the company's booth (#218) during the ASCRS conference. These presentations are designed to allow conference attendees to hear directly from recognized leaders in refractive surgery about the LensAR Laser System's latest clinical results, performance and ease of use, as well as the system's future potential for all laser limbal relaxing incisions (LRIs), clear corneal incisions (CCIs) and presbyopia correction. Featured speakers will include:

Conference attendees are also invited to visit the company's booth (#218) for a video demonstration of the LensAR Laser System.

It should be noted that the LensAR Laser System is not cleared for sale in the United States at this time. It is an investigational device limited by United States law to investigational use only.

About LensAR, Inc.

LensAR, Inc. is a leading developer of next generation laser technology for cataract surgery and other ocular applications, including presbyopia. The LensAR Laser System, which integrates an advanced femtosecond (short pulse) laser with propriety ocular measurement and laser scanning technologies, is being designed to allow physicians to perform several of the steps in cataract surgery (capsulotomy, lens fragmentation, precise astigmatic corrections and unique clear corneal incisions) in a single laser procedure. In addition to advancing its laser technology in the area of cataract surgery, the company is also developing the LensAR Laser System for the treatment of presbyopia.

For more information on LensAR and its laser technology, please visit our website at www.lensar.com

-- Femtosecond Laser Treatment of Crystalline Lens for Presbyopia: Presented by Ronald Krueger, M.D., medical director, Department of Refractive Surgery, Division of Ophthalmology, Cole Eye Institute, Cleveland Clinic Foundation; 8:32 - 8:37 a.m., April 12, 2010 -- Alternative Fragmentation Patterns in Femtosecond Laser Cataract Surgery: Presented by William J. Fishkind, M.D., director of the Fishkind, Bakewell & Maltzman Eye Care and Surgery Center in Tucson, and clinical professor at the University of Utah; 8:42 - 8:47 a.m., April 12, 2010 -- Clinical Results from the Use of a Femtosecond Laser in Cataract Surgery: Presented by Ramon Naranjo Tackman, M.D., director of Corneal and Refractive Surgery, National University of Mexico, and professor of ophthalmology, Panamerican University School of Medicine, Mexico City; 1:12 - 1:17 p.m., April 12, 2010 -- Use of Femtosecond Lasers to Create Corneal Incisions: Presented by Louis D. "Skip" Nichamin, M.D., medical director of the Laurel Eye Clinic Center in Brookville, PA; 1:17 - 1:22 p.m., April 12, 2010

SOURCE LensAR, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Online Think Tank Studies Daily Emotional Requirem...
S
Shire Presents Positive Data for Patients with Typ...